These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24750573)

  • 1. Patent Funded Access to Medicines.
    Andreassen T
    Dev World Bioeth; 2015 Dec; 15(3):152-61. PubMed ID: 24750573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 3. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 4. Essential drugs in the new international economic environment.
    Velásquez G; Boulet P
    Bull World Health Organ; 1999; 77(3):288-92. PubMed ID: 10212525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 6. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic justification for open access to essential medicine patents in developing countries.
    Flynn S; Hollis A; Palmedo M
    J Law Med Ethics; 2009; 37(2):184-208. PubMed ID: 19493066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patents and access to drugs in developing countries: an ethical analysis.
    Sterckx S
    Dev World Bioeth; 2004 May; 4(1):58-75. PubMed ID: 15086374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do patents and economic policies affect access to essential medicines in developing countries?
    Attaran A
    Health Aff (Millwood); 2004; 23(3):155-66. PubMed ID: 15160813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World pharmaceutical developments.
    Bale H
    World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745
    [No Abstract]   [Full Text] [Related]  

  • 12. The responsibility of research universities to promote access to essential medicines.
    't Hoen EF
    Yale J Health Policy Law Ethics; 2003; 3(2):293-300. PubMed ID: 14577145
    [No Abstract]   [Full Text] [Related]  

  • 13. [Access to essential drugs in developing countries].
    Rojo P
    Gac Sanit; 2001; 15(6):540-5. PubMed ID: 11858791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 15. Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.
    Bird RC
    J Law Med Ethics; 2009; 37(2):209-21. PubMed ID: 19493067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in global access to medicines threatened by funding shortfalls, warns charity.
    Moszynski P
    BMJ; 2011 Dec; 343():d8322. PubMed ID: 22205708
    [No Abstract]   [Full Text] [Related]  

  • 17. Basic survival needs and access to medicines--coming to grips with TRIPS: conversion + calculation.
    Van Puymbroeck RV
    J Law Med Ethics; 2010; 38(3):520-49. PubMed ID: 20880239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Providing affordable essential medicines to African households: the missing policies and institutions for price containment.
    Tetteh Ek
    Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fair deal for the future: flexibilities under TRIPS.
    So AD
    Bull World Health Organ; 2004 Nov; 82(11):813. PubMed ID: 15640914
    [No Abstract]   [Full Text] [Related]  

  • 20. Patents and access to essential drugs.
    Loff B
    Trans R Soc Trop Med Hyg; 2003; 97(1):6-9. PubMed ID: 12886793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.